Increased Competition, Divestitures Will Highlight 2015 Deal-Making – PwC
This article was originally published in The Tan Sheet
Executive Summary
The Actavis/Allergan merger and associated deals kicked off a major consolidation in the generics sector, which continues with Teva’s bid for Mylan, deals report shows. As the players get bigger, they’ll be looking to diversify and will drive up competition.